We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACMR icon
176
ACM Research
ACMR
$4.98B
$2.84M 0.2%
121,602
+13,572
+13% +$310K
FLNC icon
177
Fluence Energy
FLNC
$1.68B
$2.84M 0.2%
585,084
+558,967
+2,140% +$5.35M
KROS icon
178
Keros Therapeutics
KROS
$199M
$2.81M 0.2%
+276,060
New +$3.21M
WRBY icon
179
Warby Parker
WRBY
$3.19B
$2.81M 0.2%
154,036
+110,789
+256% +$2.64M
DLO icon
180
dLocal
DLO
$4.38B
$2.8M 0.2%
336,191
-19,394
-5% -$218K
PAY icon
181
Paymentus
PAY
$4.29B
$2.77M 0.2%
106,265
+42,888
+68% +$1.27M
RDDT icon
182
Reddit
RDDT
$34.4B
$2.77M 0.2%
26,404
+3,304
+14% +$546K
RAMP icon
183
LiveRamp
RAMP
$2.29B
$2.73M 0.19%
104,500
+10,740
+11% +$329K
AROC icon
184
Archrock
AROC
$6.19B
$2.68M 0.19%
102,050
-54,764
-35% -$1.48M
RMD icon
185
ResMed
RMD
$30.3B
$2.65M 0.19%
11,835
+300
+3% +$70K
XMTR icon
186
Xometry
XMTR
$4.58B
$2.65M 0.19%
+106,241
New +$3.34M
AVDX
187
DELISTED
AvidXchange
AVDX
$2.63M 0.19%
309,693
INCY icon
188
Incyte
INCY
$26B
$2.61M 0.19%
43,168
+39,834
+1,195% +$2.78M
DOCS icon
189
Doximity
DOCS
$3.85B
$2.59M 0.18%
44,564
-1,399
-3% -$88.3K
ADPT icon
190
Adaptive Biotechnologies
ADPT
$3.6B
$2.56M 0.18%
344,978
+28,697
+9% +$221K
PH icon
191
Parker-Hannifin
PH
$125B
$2.55M 0.18%
4,200
GILD icon
192
Gilead Sciences
GILD
$167B
$2.53M 0.18%
22,600
+1,496
+7% +$154K
AUPH icon
193
Aurinia Pharmaceuticals
AUPH
$1.92B
$2.53M 0.18%
314,519
+12,966
+4% +$105K
DD icon
194
DuPont de Nemours
DD
$19B
$2.53M 0.18%
+26,941
New +$2.63M
GE icon
195
GE Aerospace
GE
$377B
$2.52M 0.18%
+12,603
New +$2.48M
CHEF icon
196
Chefs' Warehouse
CHEF
$4.09B
$2.52M 0.18%
46,295
+3,622
+8% +$202K
CCK icon
197
Crown Holdings
CCK
$13.2B
$2.51M 0.18%
28,140
-2,773
-9% -$242K
LZ icon
198
LegalZoom.com
LZ
$1.39B
$2.51M 0.18%
291,045
-407
-0.1% -$3.64K
TLN
199
Talen Energy Corp
TLN
$15.6B
$2.49M 0.18%
+12,494
New +$2.71M
MFC icon
200
Manulife Financial
MFC
$74.2B
$2.47M 0.18%
+79,346
New +$2.4M

Similar funds

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.